Dr Robson is a nephrologist with clinical and research interests in both glomerulonephritis and haemodialysis. He has a long record of laboratory research in experimental glomerulonephritis and is one of the lead consultants for a specialist clinic for patients with lupus, vasculitis and glomerular disease. He was also the Chief Investigator for the UK-wide PAVE trial, assessing drug-coated balloons in the treatment of arteriovenous fistulas.
Current research projects are clinical studies in patients on haemodialysis and in patients with lupus nephritis.
People
Clinical Trial Manager
Consultant nephrologist
Clinical Trial Manager
Clinical Research Fellow
Projects
Paclitaxel or sirolimus coated balloons used for ArterioVEnous fistulas - 2 (PAVE-2 trial)
A UK-wide randomised controlled clinical trial to determine the efficacy of paclitaxel or sirolimus coated balloons in arteriovenous fistulas used for haemodialysis.
Colchicine And Dialysis patients; a feasibility study (CAD)
The primary objective of this study is to assess the feasibility of carrying out future trials of colchicine in dialysis patients.
Publications
People
Clinical Trial Manager
Consultant nephrologist
Clinical Trial Manager
Clinical Research Fellow
Projects
Paclitaxel or sirolimus coated balloons used for ArterioVEnous fistulas - 2 (PAVE-2 trial)
A UK-wide randomised controlled clinical trial to determine the efficacy of paclitaxel or sirolimus coated balloons in arteriovenous fistulas used for haemodialysis.
Colchicine And Dialysis patients; a feasibility study (CAD)
The primary objective of this study is to assess the feasibility of carrying out future trials of colchicine in dialysis patients.
Publications
Our Partners
National Institute for Health Research (NIHR)
Group lead
Consultant nephrologist